Complete Guide to Tacrolimus model Pharmacokinetics
Overview
Tacrolimus model is a Calcineurin inhibitor (Immunosuppressant) used in the Transplantation / Nephrology therapeutic area. It is indicated for Kidney transplant immunosuppression. Interactive tacrolimus population PK simulator with CYP3A genotype-guided dosing (PM/IM/EM) for kidney transplant recipients. Based on Woillard et al. 2017.
Mechanism of Action
Tacrolimus model exerts its pharmacological effect by targeting Calcineurin. As a Calcineurin inhibitor (Immunosuppressant), it modulates this target to achieve therapeutic efficacy in Kidney transplant immunosuppression. Understanding the target engagement is critical for interpreting the pharmacokinetic-pharmacodynamic (PK/PD) relationship and optimizing dosing regimens.
Key Pharmacokinetic Parameters
The following parameters are derived from published PopPK models for Tacrolimus model:
| Parameter | Value |
|---|---|
| F | 0.16 |
| Ka | 0.23 h⁻¹ |
| V F | 3.3 L/kg |
| CL F | 0.99 L/h/kg (PM genotype) |
| t half | ~12 h |
| covariates | CYP3A genotype (PM/IM/EM), body weight |
Parameters represent typical population estimates from published literature. Individual values may vary.
Dosing & Administration
Tacrolimus model is administered via the Oral route. Oral administration involves absorption from the gastrointestinal tract, and bioavailability may be affected by food intake, formulation, and first-pass metabolism.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Transplantation / Nephrology therapeutic area, for the treatment of Kidney transplant immunosuppression, understanding the pharmacokinetics of Tacrolimus model is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Tacrolimus model pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Tacrolimus model PK Simulator
Explore Tacrolimus model pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Tacrolimus model?
The elimination half-life of Tacrolimus model depends on patient-specific factors. Based on published models, the typical half-life is approximately ~12 h.
How is Tacrolimus model administered?
Tacrolimus model is administered via the Oral route. It is indicated for Kidney transplant immunosuppression. As a Calcineurin inhibitor (Immunosuppressant), dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Tacrolimus model?
Key pharmacokinetic parameters for Tacrolimus model include clearance (CL), volume of distribution (Vd), and elimination half-life. See the PK Parameters section above for specific values from published models.
Can I simulate Tacrolimus model dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Tacrolimus model PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.